B2M and cancer: We found that the elevated MHC-I levels on tumor cells surface after knocking out circGRAMD4, RBM4, and NBR1 decreased again with the knockout of B2M (Figure S7D), and the corresponding changes in cancer cell death (Figure S7E) and CD8+ T cytokine levels also occurred (Figure S7F).